Human factors research in the support of medical and drug delivery device commercialization is essential and we should be planning on a return to in-person research as soon as is possible by applying all available and practical protective measures.
Back to team page
Kaitlin Carter
Director
Kaitlin (known to many by their nickname Indy) approaches every project with the multidisciplinary lens of 5+ years of experience in both human factors and UX. Their passion lies in human factors studies, ranging from complex drug delivery systems to software as medical device (SaMD). Their research background in linguistic and business anthropology offers clients insight from various industries that can be applied to every research question. Kaitlin has a BA in Cultural Anthropology and an MA in Business and Organizational Anthropology from Wayne State University.
Bold facts
Learn more about

Something unique about you summed up in one sentence:

Your favorite part of working at Bold Insight:

Do you have a long-term personal or professional goal you'd like to share?
How long have you been in the UX field?

You cannot start the day without doing this...
Your favorite city in the world is...and why?

Your ultimate celebrity dinner party guest list would include:

Any other facts to share?
- Generative AI is rewriting user expectations
- Bold Insight presents with Stryker, Genentech, and AbbVie at the HFES Healthcare Symposium
- How to show up for your participants and colleagues this Pride Month and beyond
- Bold Insight to present on IFU design, digital telemetry, and other human factors topics at HFES Healthcare Symposium
Read our team’s latest bold insights
COVID-19: Using human factors and UX to make a positive impact
We have aggregated some considerations for HCPs, healthcare organizations, and others involved in the medical space.
Is FMEA inadequate for human factors analyses?
A “traditional” risk assessment does not meet the needs of FDA-required human factors analyses.
Pros and cons of remote moderated testing: Considerations for ongoing research during COVID-19
A few key adjustments can help capture research data effectively and ensure the health of participants and team members.